MRT-2359
Monte Rosa Therapeutics
[]
monte rosa therapeutics presents preclinical data from gspt1 degrader program focused on myc-driven cancers at aacr 2023 $glue 
Real-Time News, Market Data and Stock Quotes for Biotech, Pharma, and Healthcare Stocks